Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Insights into molecular mechanisms that drive hyperglycemia and T2D: E2F3 increases CyclinD1 expression and inhibits gluconeogenesis via transcriptional regulation of Peroxisome proliferator-activated receptor γ coactivator-1α, 15/September/2014, 5.46 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
Significance: This study suggests that E2F3, by decreasing the expression of its target gene, it may inhibit gluconeogenesis. Thus, pharmacological formulations encompassing “E2F3 activators” may be used to treat DM.
* Research cooperation
